Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow mesenchymal stem cell infusion for acute cervical spinal cord injury
jRCT2091220154Completed
- Sponsor
- Toshihiko Yamashita, MD, PhD
- Start
- Dec 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous bone marrow derived mesenchymal stromal cells in Spinal cord injury (SCI), sponsored by Toshihiko Yamashita, MD, PhD. Primary endpoint: ASIA impairment scale improvement ≥1 grade. Started Dec 2013; status: completed.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
Spinal cord injury (SCI)
Beyond the preview
Go deeper on jRCT2091220154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220154.